Insider Trading February 3, 2026

Renasant Executive Disposes of 6,000 RNST Shares; Company Posts Strong Q4 2025 Results

EVP/General Counsel reduces holdings while the bank reports EPS and revenue that topped analyst estimates

By Derek Hwang RNST
Renasant Executive Disposes of 6,000 RNST Shares; Company Posts Strong Q4 2025 Results
RNST

Renasant Corporation's executive vice president and general counsel sold 6,000 shares of the company's common stock on February 2, 2026, for $37.8798 per share, generating $227,278 in proceeds. After the sale, the executive holds 65,172 shares. Separately, Renasant reported fourth-quarter 2025 adjusted EPS of $0.91 on revenue of $278.52 million, both modestly ahead of analysts' forecasts.

Key Points

  • An EVP and general counsel at Renasant sold 6,000 shares on February 2, 2026, for a total of $227,278, leaving him with 65,172 shares directly owned.
  • Renasant's adjusted EPS for Q4 2025 was $0.91, topping the forecasted $0.78 and constituting a 16.67% upside versus expectations.
  • Quarterly revenue was $278.52 million, marginally exceeding the projected $275.85 million; these figures are central to investor assessment of recent financial performance.

An executive at Renasant Corporation completed a sale of company stock on February 2, 2026, reducing his stake by 6,000 shares. The shares traded at $37.8798 each, producing total proceeds of $227,278. Following this transaction, the executive directly holds 65,172 shares of Renasant common stock.

The transaction involved the company's executive vice president and general counsel. The sale is recorded as a direct disposal of common shares and the post-sale ownership figures remain publicly reported. No additional transactions or changes to ownership beyond the stated sale are disclosed in the reporting details provided.

In related corporate disclosures, Renasant Corporation released its financial results for the fourth quarter of 2025. The bank posted adjusted earnings per share of $0.91, exceeding the consensus expectation of $0.78. The magnitude of the upside versus forecasts is reported as a 16.67% surprise. Revenue for the quarter came in at $278.52 million, which also topped the anticipated $275.85 million figure.

These reported earnings and revenue figures indicate the company delivered results above analyst projections for the quarter. The adjusted EPS outperformance and the modest revenue beat are key financial metrics that investors and observers use to assess near-term operating performance and profitability. The data provided is limited to the quarterly EPS and revenue comparisons to analyst expectations; no further operational details, guidance, or commentary from company management are included in the information supplied.

For market participants tracking insider activity and corporate earnings, this combination of an insider share sale and an earnings beat provides discrete data points to consider. The insider sale amount, the executive's remaining direct ownership, and the quarterly financial figures are the specific factual elements disclosed. There is no additional commentary here on the motivations behind the sale or any forward-looking projections beyond the stated quarterly results.


What happened

  • 6,000 Renasant shares were sold on February 2, 2026, at $37.8798 per share for $227,278 in total proceeds.
  • The selling executive directly owns 65,172 shares after the transaction.
  • Renasant reported Q4 2025 adjusted EPS of $0.91 and revenue of $278.52 million, both above analyst estimates.

Risks

  • Insider sales can be interpreted in multiple ways; the reporting provides no explanation for the transaction and does not indicate any change in company guidance or strategy - impacts relevant to investor sentiment in the banking sector.
  • Quarterly results are limited to adjusted EPS and revenue figures with no additional operational detail or forward-looking guidance provided, leaving uncertainty for future performance assessment - relevant to financial markets and bank equity valuations.

More from Insider Trading

Eagle Financial Director Acquires $22,680 of Stock as Bank Reports Modest Q4 Miss Feb 3, 2026 Hot GFG LLC Disposes of All Fat Brands Class A Shares as Company Moves Through Chapter 11 Proceedings Feb 3, 2026 Serina Therapeutics CSO Disposes of $19,680 in Stock as Company Advances SER-252 Program Feb 3, 2026 Vir Biotechnology Director Sells $169,670 in Stock Amid Positive Clinical and Commercial Updates Feb 3, 2026 Horizon Kinetics Records Single-Share Buy in Texas Pacific Land; Company Reports Q3 Shortfalls, New Data-Center Partnership Feb 3, 2026